Consumer Reports comments on Proposed Final Judgment in CVS-Aetna merger

On December 17, 2018, Consumer Reports joined allied consumer advocacy organizations that are concerned about the high cost of prescription drugs, escalating health care costs, and lack of meaningful patient choice. We submitted comments on the proposed Final Judgment (“PFJ”) by the court reviewing the merger. Our comments were submitted to assist the U.S. Department of Justice (“DOJ”) and the district court in the review of whether the PFJ is sufficiently complete to remedy the competitive problems identified in the DOJ’s complaint as well as the wide range of other anticompetitive problems presented by the merger of CVS Health Corporation (“CVS”) and Aetna Inc. (“Aetna”).